Stock SYNGENE SYNGENE INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Syngene International Limited

Equities

SYNGENE

INE398R01022

Market Closed - NSE India S.E.
Other stock markets
 12:40:31 08/05/2024 BST 		5-day change 1st Jan Change
665.8 INR -0.49% Intraday chart for Syngene International Limited -3.40% -5.09%
04-28 Syngene International Limited Submits an Appeal to the National Faceless Appeal Centre, for Assessment Year 2022-23 CI
04-26 Jefferies Downgrades Syngene International to Underperform From Hold, Adjusts Price Target to INR620 From INR690 MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Syngene International Limited Recommends Final Dividend for the Financial Year 2024
Syngene International Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Syngene International Limited Reports Earnings Results for the Full Year Ended March 31, 2024
INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes
Syngene Biologics Manufacturing Facility to Be Operational for U.S. and European Customers from Mid-Year
Bristol Myers CEO says India to have largest R&D presence outside US by 2025
Syngene International Posts Gains in Fiscal Q3 Consolidated Net Profit
Syngene International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Syngene International Limited Appoints Mr. Sibaji Biswas as Additional Director Designated as Executive Director, Effective on April 01, 2024
Syngene International Completes Acquisition of Stelis Biopharma's Biologics Plant
Syngene International Limited completed the acquisition of Unit 3 biologics manufacturing facility in Bangalore from Stelis Biopharma Private Limited for INR 6.2 billion.
FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China
Syngene International COO Steps Down
Syngene International Limited Announces Resignation of Mahesh Bhalgat as Chief Operating Officer, Effective January 31, 2024
Syngene International Limited Announces Resignation of Carl Decicco as Non-Executive Director
Syngene International's Consolidated Profit Jumps in Fiscal Q2; Shares Slump 7%
Syngene International Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Syngene International Limited Announces Retirement of Joydeep Kant as Sr. Vice President - Development Services, Effective October 31, 2023
Syngene International Limited Approves A Final Dividend for the Financial Year Ended March 31, 2023
Syngene International Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SYNGENE Stock
  4. News Syngene International Limited
  5. Other languages